Abstract
Dialysate and serum levels of granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage colony stimulating factor (GM-CSF) and leukemia inhibitory factor (LIF) were analyzed in patients with continuous ambulatory peritoneal dialysis (CAPD). Samples from the peritoneal effluent and from serum were obtained during the first months of dialysis and during peritonitis from the first three dialysate bags drained on the day of admittance and from nightbags on days three and ten. Serum samples were drawn on days one and ten. On the first day of infection G-CSF was detected in twelve out of fifteen samples in the dialysate and reached its peak median level, 443 pg/ml, in the first drained bag and thereafter decreased significantly. Also in serum a peak, 190 pg/ml, was observed on the first day. LIF was found in six of ten analyzed dialysate samples, with a peak median level of 77 pg/ml on day one, while only four of ten patients had detectable GM-CSF. Peripheral blood mononuclear cells from non-infected CAPD patients were stimulated with lipopolysacharide and G-CSF levels in the supernatants increased significantly (P < 0.05) after 6 h stimulation. We conclude that G-CSF is produced locally in the dialysate during the acute stage of peritonitis and to a lesser extent also systemically. These findings are in line with G-CSF production after LPS stimulation of peripheral blood mononuclear cells.
Similar content being viewed by others
REFERENCES
Weisbart, R. H., J. C. Gasson, and D. W. Golde. 1989. Colony-stimulating factors and host defense. Ann. Intern. Med. 110:297–303.
Souoza, L. M., T. C. Boone, J. Bagrilove, P. H. Lai, K. Zsebo, D. C. Murdock, V. R. Chazin, J. Bruszewski, H. Lu, K. K. Chen, J. Barendt, E. Platzer, M. A. S. Moore, R. Mertelsmann, and K. Welte. 1986. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61–65.
Freedman, M. H. 1997. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr. Opinion Hematol. 4:217–224.
Nelson, S. 1994. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host: an overview. Clin. Infect. Dis. 18(Suppl 2):S197–204.
Roilides, E. and P.A. Pizzo. 1992. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:508–524.
Selgas, R., M. Fernadez de Castro, C. Jimenez, C. Carcamo, T. Contreras, M. A. Bajo, F. Vara, and A. Corbi. 1996. Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony stimulating factor in humans. Kidn. Int. 50:2070–2078.
Mayer, P., K. Geissler, M. Ward, and D. Metcalf. 1993. Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81:3226–3333.
Block, M. I., M. Berg, M. J. McNamara, J. A. Norton, D. L. Fraker, and H. R. Alexander. 1993. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 178:1085–1090.
Cebon, J., J. E. Laytonn, D. Maher, and G. Morstyn. 1994. Endogenous haemopoietic growth factors in neutropenia and infection. Br. J. Haematol. 86:265–274.
Kawakami, M., H. Tsutsumi, T. Kumakawa, H. Abe, M. Hirai, S. Kurosawa, M. Mori, and M. Fukushima. 1990. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962–1964.
Price, T. H., G. S. Chatta, and D. C. Dale. 1996. Effect of recombinat granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335–340.
De Vecci, A., P. Zanon, A. Scalamogna, and C. Ponticelli. 1994. Granulocyte-colonystimulating factor in patients treated by continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transpl. 9:1843–1844.
Dale, D. C., W. C. Liles, W. R. Summer, and S. Nelson. 1995. Granulocyte colony-stimulating factor-role and relationships in infectious diseases. J. Infect. Dis. 172:1061–1075.
Krause, S. W., M. Kreutz, and R. Andreesen. 1997. Differential effects of cell adherence on LPS-stimulated cytokine production by human monocytes and macrophages. Immunobiol. 196:522–534.
Rennick, D., G. Yang, L. Gemmel, and F. Lee. 1987. Control of hemopoiesis by bone marrow stromal cell clone: lipopolysaccharide-and interleukin-1 inducible production of colony-stimulating factors. Blood 69:682–691.
Fernandez de Castro, M., R. Selgas, C. Jimenez, M. A. Bajo, V. Martinez, J. Romero, F. De Alvaro, and F. Vara. 1994. Cell populations present in the noctural peritoneal effluent of patients on CAPD and their relationship with peritoneal function and incidence of peritonitis. Perit. Dial. Int. 14:265–270.
Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Beoley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J. Clin. Invest. 78:1220–1228.
Waring, P. M., L. J. Waring, and D. Metcalf. 1994. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcema. J. Infect. Dis. 170:1224–1228.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brauner, A., Hylander, B. & Lu, Y. Granulocyte Stimulating Factor in Patients on Peritoneal Dialysis and LPS Stimulated Peripheral Blood Mononuclear Cells. Inflammation 22, 393–401 (1998). https://doi.org/10.1023/A:1022320916105
Issue Date:
DOI: https://doi.org/10.1023/A:1022320916105